EDWARD C. ALBINI - 29 Jan 2024 Form 4 Insider Report for SUTRO BIOPHARMA, INC. (STRO)

Role
CFO AND SECRETARY
Signature
/s/ Edward C. Albini
Issuer symbol
STRO
Transactions as of
29 Jan 2024
Net transactions value
-$10,733
Form type
4
Filing time
31 Jan 2024, 16:28:00 UTC
Previous filing
07 Mar 2023
Next filing
05 Mar 2024
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction STRO Common Stock Options Exercise $0 +5,250 +6% $0.000000 92,943 29 Jan 2024 Direct
transaction STRO Common Stock Tax liability $10,733 -2,151 -2.3% $4.99 90,792 29 Jan 2024 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction STRO Restricted Stock Unit (RSU) Options Exercise $0 -5,250 -100% $0.000000* 0 29 Jan 2024 Common Stock 5,250 Direct F2, F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents the number of shares of Common Stock that have been withheld by the issuer to satisfy its income tax withholding and remittance obligations in connection with the net settlement of the RSUs and does not represent a sale by the reporting person.
F2 Each RSU represents a contingent right to receive one (1) share of the issuer's Common Stock upon settlement.
F3 The RSUs vest as to 1/4th of the total shares annually beginning on January 29, 2021, subject to continued service through each vesting date.